Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 6/20 | 0.39 |
| ▸ | GSK3B | P49841 | 3/20 | 0.39 |
| ▸ | CDK7 | P50613 | 13/20 | 0.36 |
| ▸ | CCNH | P51946 | 13/20 | 0.36 |
| ▸ | MNAT1 | P51948 | 13/20 | 0.36 |
| ▸ | HAVCR2 | Q8TDQ0 | 3/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.32 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.31 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.31 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23529884 | 0.79 | XDH (0.36) | CDK2CDK7CCNHMNAT1HAVCR2 | |
| SCHEMBL18510365 | 0.78 | CDK7 (0.34) | CDK2GSK3BCDK7CCNHMNAT1 | |
| SCHEMBL24408250 | 0.78 | HAVCR2 (0.35) | CDK2GSK3BCDK7CCNHMNAT1 | |
| SCHEMBL15224509 | 0.75 | LMNA (0.36) | CDK2CDK7CCNHMNAT1HAVCR2 | |
| SCHEMBL29174858 | 0.73 | HTR2C (0.51) | CDK2CDK7CCNHMNAT1CCNE1 | |
| SCHEMBL15245996 | 0.71 | CDK2 (0.40) | CDK2GSK3BCDK7CCNHMNAT1 | |
| SCHEMBL15238119 | 0.71 | CDK2 (0.40) | CDK2GSK3BCDK7CCNHMNAT1 | |
| SCHEMBL15224590 | 0.70 | CDK2 (0.39) | CDK2GSK3BCDK7CCNHMNAT1 | |
| SCHEMBL18520998 | 0.68 | ALDH1A1 (0.39) | CDK2GSK3BALDH1A1HPGD | |
| SCHEMBL24236930 | 0.68 | HTR2C (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020035049-A1 | DEGRADATION AGENTS FOR CYCLIN DEPENDENT KINASE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 中国科学院上海药物研究所 | 2020-02-20 | — | — | WO | disclosed |